Order
Press Releases

Market Release of AlphaFlo® Canine Allograft

AlphaFlo-Press-Release-Image

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

Read the Press Release
Other Posts

Is AlphaFlo® the Same as a Stem Cell Therapy?

Quick answer: No, AlphaFlo® and stem cell therapies are different categories of products. AlphaFlo® is an acellular, canine amniotic tissue allograft derived from placental tissue. A stem cell therapy, by contrast, is comprised of living cells extracted from a...

CASE STUDY: Intervertebral Disc Disease

On January 12, 2026, patient presented with severe Intervertebral Disc Disease (IVDD). Bear is a 14-year-old, neutered, male Siberian Husky. Symptoms included lower back pain, back leg placement issues with nail dragging, and would collapse at times with stairs....

CASE STUDY: Bilateral Knee Osteoarthritis

On June 18, 2025, a 10-year-old, spayed, female Belgian Malinois presented with bilateral knee osteoarthritis. Lameness and pain were reported for several months. Patient had received PRP and stem cell injections previously with no reported improvement. At the...